Episodes

  • Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia

    Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia
    May 14 2024
    Drs Naval Daver and Courtney D DiNardo, both from The University of Texas MD Anderson Cancer Center in Houston, summarize the clinical progress in diagnosing and treating acute myeloid leukemia over the past year, as well as practical considerations for patients with the disease.
    Show More Show Less
    1 hr and 2 mins
  • Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series

    Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series
    May 2 2024
    Dr Ruben A Mesa from Wake Forest University School of Medicine in Winston-Salem, North Carolina, discusses recent updates on available and novel treatment strategies for myelofibrosis.
    Show More Show Less
    1 hr and 1 min
  • Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria

    Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria
    Apr 26 2024
    Dr Carlos de Castro, Prof Alexander Röth and Dr Ilene Weitz summarize the biology of paroxysmal nocturnal hemoglobinuria, current treatment approaches, and practical considerations for patients with the disease.
    Show More Show Less
    1 hr and 37 mins
  • Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences

    Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences
    Apr 24 2024
    Dr Naveen Pemmaraju from The University of Texas MD Anderson Cancer Center in Houston discusses updated findings from ASH 2023 on management approaches for myelofibrosis and polycythemia vera.
    Show More Show Less
    1 hr and 5 mins
  • Oncology Today with Dr Neil Love: Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences

    Oncology Today with Dr Neil Love: Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences
    Apr 12 2024
    Dr Bita Fakhri from Stanford University in Stanford, California, discusses recent updates from ASH 2023 for the management of chronic lymphocytic leukemia and Richter’s syndrome.
    Show More Show Less
    1 hr and 35 mins
  • Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma

    Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma
    Mar 27 2024
    Dr Andrew M Evens from the Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Sonali M Smith from the University of Chicago in Illinois discuss clinical decision-making with numerous treatment strategies for lymphoma.
    Show More Show Less
    1 hr
  • Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series

    Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series
    Mar 8 2024
    Dr Stephen T Oh from Washington University School of Medicine in St Louis, Missouri, discusses current and emerging monitoring and management strategies for myelofibrosis.
    Show More Show Less
    1 hr
  • Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia

    Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia
    Feb 27 2024
    Dr Lindsey Roeker from Memorial Sloan Kettering Cancer Center in New York, New York, and Dr Jeff Sharman of the US Oncology Network in Eugene, Oregon, discuss relevant datasets from 2023 on the management of chronic lymphocytic leukemia.
    Show More Show Less
    58 mins